What is VivoSim Labs, Inc. (VIVS) stock price today?

VivoSim Labs, Inc. (VIVS) currently trades at $1.44 per share. The stock has a market capitalization of $4.34M and a P/E ratio of 0.85x.

Is VIVS stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, VivoSim Labs, Inc. has a Smart Value Score of 27/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is the VIVS stock price target for 2026?

WallStSmart's 12-month price target for VivoSim Labs, Inc. is $1.62.

What is VivoSim Labs, Inc.'s revenue and earnings?

VivoSim Labs, Inc. has trailing twelve-month (TTM) revenue of $142000.00 with profit margins of 0.00%. Earnings per share (EPS) is $1.76.

VIVS

VivoSim Labs, Inc.

NASDAQ: VIVS · HEALTHCARE · BIOTECHNOLOGY

$1.44

-3.36% today

Updated 2026-04-29

Market cap

$4.34M

P/E ratio

0.85

P/S ratio

30.58x

EPS (TTM)

$1.76

Dividend yield

—

52W range

$1 – $5

Volume

0.1M

Market cap

$4.34M

P/E ratio

0.85

P/S ratio

30.58x

EPS (TTM)

$1.76

Dividend yield

—

52W range

$1 – $5

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.0

Growth

5.0

Quality

C+

2.5

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$—

—

12-Month target

$1.62

+12.50%

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-2.27M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$1.50M	$370000.00	$109000.00	$144000.00	$142000.00
Net income	$-11.45M	$-17.26M	$-14.67M	$-2.49M	$-2.69M
EPS	—	—	—	—	$1.76
Free cash flow	$-8.86M	$-12.80M	$-14.70M	$-9.47M	$-2.27M
Profit margin	-763.20%	-4,664.59%	-13,459.63%	-1,727.78%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
VIVS	$4.34M	27	4.0	2.5	6.7	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

VivoSim Labs, Inc. trades at $1.44. representing a P/E of 0.85x trailing earnings. Our Smart Value Score of 27/100 indicates the stock is weak. TTM revenue stands at $142000.00.

Frequently asked questions

What is VivoSim Labs, Inc.'s stock price?

VivoSim Labs, Inc. (VIVS) trades at $1.44.

Is VivoSim Labs, Inc. overvalued?

Smart Value Score 27/100 (Grade F, Strong Sell).

What is the price target of VivoSim Labs, Inc. (VIVS)?

The analyst target price is $—, representing NaN% downside from the current price of $1.44.

What is VivoSim Labs, Inc.'s revenue?

TTM revenue is $142000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio30.58x

ROE-51.10%

Beta1.44

50D MA$1.74

200D MA$2.20

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

VIVS vs LLY →VIVS vs JNJ →VIVS vs ABBV →Stock screener →